22-12-2010, 04:57 PM
(22-12-2010, 04:51 PM)Nick Wrote: Hi MW,
I think the latest right issue should shore up Biotreat balance sheet to some extent. But BOT projects are pretty capital intensive so financing is the key. But lets remember that $4 million is pretty small sum compared to Boustead's cash hoard so this could just be an opportunistic bet.
Yes, correct, $4 million is a small sum compared to what Boustead has. So they will account for it under AFS investments in the Balance Sheet under Long-Term Assets.

My Value Investing Blog: http://sgmusicwhiz.blogspot.com/